← All stocks

BIOCRYST PHARMACEUTICALS INC

BCRX Net buying
CIK 0000882796 #1887 in the set updated 19 Sep 2026
Bought (120 mo)
$2.11M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$30.94M
$1.03M on a plan · $28.10M straight out of an exercise
Sold at will
$1.81M
21 of 114 sales
Net
−$28.83M
+$302.39K against sales at will

By person

28 insiders · 159 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Stonehouse Jon P
Director
$239.00K (2)
$9.66M (7) scheduled
−$9.42M
1,460,419
0.5715%
$13.10M
+97.2%
Sheridan William P
Chief Medical Officer
$6.82M (9) scheduled
−$6.82M
37,954
0.0149%
$340.45K
−67.1%
Barnes Alane P
Chief Legal Officer
$56.65K (2)
$5.34M (12) scheduled
−$5.29M
400,703
0.1568%
$3.59M
+321.3%
Hutson Nancy J
Director
$46.40K (2)
$2.17M (4) scheduled
−$2.12M
99,138
0.0388%
$889.27K
+268.9%
ABERCROMBIE GEORGE B
Director
$1.66M (8) scheduled
−$1.66M
36,431
0.0143%
$326.79K
+264.3%
STAAB THOMAS R II
Senior Vice President and CFO
$1.30M (34) scheduled
−$1.30M
125,176
0.0490%
$1.12M
+0.8%
HEGGIE THERESA
Director
$7.25K (1)
$1.14M (3) scheduled
−$1.13M
80,646
0.0316%
$723.39K
Babu Yarlagadda S
Chief Discovery Officer
$36.25K (1)
$1.15M (3) scheduled
−$1.11M
298,541
0.1168%
$2.68M
+167.9%
Doyle Anthony
Chief Financial Officer
$862.53K (3)
$62.13K (1)
+$800.40K
377,867
0.1479%
$3.39M
Powell Lynne
Senior VP - CCO
$538.73K (19) scheduled
−$538.73K
0
0.0000%
$0.00
−100.0%
Cohen Fred E
Director
$294.04K (1) scheduled
−$294.04K
119,410
0.0467%
$1.07M
+4.7%
MILANO VINCENT
Director
$185.18K (2)
+$185.18K
109,642
0.0429%
$983.49K
+996.4%
Jones Michael L
Exec. Director, Finance - PAO
$156.30K (3) scheduled
−$156.30K
16,653
0.0065%
$149.38K
+1,864%
McKee Amy E
Director
$154.64K (2)
−$154.64K
47,821
0.0187%
$428.95K
SANDERS MACHELLE
Director
$128.60K (3) scheduled
−$128.60K
45,936
0.0180%
$412.05K
Galson Steven K
Director
$120.45K (1)
+$120.45K
27,794
0.0109%
$249.31K
Gayer Charles K
President and CCO
$164.10K (1)
$66.49K (1)
+$97.61K
952,583
0.3728%
$8.54M
+823.1%
LEE KENNETH B JR
Director
$7.25K (1)
$92.10K (1) scheduled
−$84.85K
68,863
0.0269%
$617.70K
+571.7%
Sniecinski Megan
Chief Business Officer
$65.25K (1)
+$65.25K
45,000
0.0176%
$403.65K
ASELAGE STEVE
Director
$65.06K (4)
+$65.06K
72,659
0.0284%
$651.75K
LEVIN ALAN G
Director
$50.00K (1)
+$50.00K
79,565
0.0311%
$713.70K
Thackray Helen M.
Chief R&D Officer
$175.80K (1)
$215.18K (3)
−$39.38K
377,318
0.1477%
$3.38M
INGRAM ROBERT ALEXANDER
Director
$29.00K (1)
+$29.00K
100,198
0.0392%
$898.78K
+4,018%
Ghias Babar
Chief Financial Officer
268,700
0.1052%
$2.41M
Menon Sandeep
Chief R&D Officer
205,150
0.0803%
$1.84M
Erck Stanley C
Director
48,333
0.0189%
$433.55K
+20.8%
Frank Steven
Director
36,747
0.0144%
$329.62K
Milne Jill C.
Director
33,226
0.0130%
$298.04K
Insider
Date
Role
Action
Shares
Price
Amount
McKee Amy E
18 May 2026
Director
Sell
11,180
$8.97
$100.28K
Barnes Alane P
13 May 2026
Chief Legal Officer
Sold after exercise
62,500
$9.54
$596.25K
HEGGIE THERESA
20 Mar 2026
Director
Sold after exercise
49,933
$10.11
$504.82K
Barnes Alane P
16 Mar 2026
Chief Legal Officer
Sold after exercise
150,000
$9.15
$1.37M
Stonehouse Jon P
2 Mar 2026
Director
Exercised, kept
305,995
$3.22
$985.30K
Gayer Charles K
22 Dec 2025
President and CCO
Exercised, kept
50,000
$5.51
$275.50K
Gayer Charles K
22 Dec 2025
President and CCO
Exercised, kept
10,091
$5.04
$50.86K
Gayer Charles K
22 Dec 2025
President and CCO
Exercised, kept
14,142
$3.22
$45.54K
Barnes Alane P
22 Dec 2025
Chief Legal Officer
Sold on a plan
21,773
$7.65
$166.56K
Barnes Alane P
15 Dec 2025
Chief Legal Officer
Sold on a plan
21,210
$7.65
$162.26K
Barnes Alane P
3 Dec 2025
Chief Legal Officer
Sold on a plan
19,770
$7.65
$151.24K
Barnes Alane P
2 Dec 2025
Chief Legal Officer
Sold on a plan
50,906
$7.21
$367.22K
Barnes Alane P
1 Dec 2025
Chief Legal Officer
Sold after exercise
91,004
$7.10
$646.51K
SANDERS MACHELLE
13 Nov 2025
Director
Sold on a plan
9,600
$7.14
$68.54K
HEGGIE THERESA
13 Aug 2025
Director
Sold after exercise
70,000
$8.51
$595.87K
Hutson Nancy J
13 Dec 2024
Director
Sold on a plan
7,000
$7.54
$52.78K
McKee Amy E
24 Jun 2024
Director
Sell
8,600
$6.32
$54.35K
SANDERS MACHELLE
17 Jun 2024
Director
Sell
4,689
$6.00
$28.13K
HEGGIE THERESA
14 Jun 2024
Director
Sell
6,698
$6.11
$40.92K
LEVIN ALAN G
30 May 2024
Director
Buy
7,861
$6.36
$50.00K
ASELAGE STEVE
24 May 2024
Director
Buy indirect
2,500
$6.40
$16.00K
MILANO VINCENT
20 May 2024
Director
Buy
15,000
$6.25
$93.75K
Hutson Nancy J
20 May 2024
Director
Buy
5,000
$6.38
$31.90K
Thackray Helen M.
14 May 2024
Chief R&D Officer
Buy
30,000
$5.86
$175.80K
Doyle Anthony
14 May 2024
Chief Financial Officer
Buy
36,300
$5.57
$202.19K
Gayer Charles K
13 May 2024
Chief Commercial Officer
Buy
30,000
$5.47
$164.10K
Stonehouse Jon P
13 May 2024
President & CEO
Buy
30,000
$5.55
$166.50K
Barnes Alane P
13 May 2024
Chief Legal Officer
Buy
5,000
$5.53
$27.65K
Galson Steven K
13 May 2024
Director
Buy
21,940
$5.49
$120.45K
SANDERS MACHELLE
15 Jun 2023
Director
Sell
4,000
$7.98
$31.92K
Hutson Nancy J
14 Jun 2023
Director
Sell
12,866
$8.04
$103.44K
Thackray Helen M.
3 Apr 2023
Chief R&D Officer
Sold on a plan
7,000
$8.29
$58.03K
Stonehouse Jon P
21 Mar 2023
President & CEO
Exercised, kept
31,055
$3.22
$100.00K
Stonehouse Jon P
1 Feb 2023
President & CEO
Sold after exercise
100,000
$10.38
$1.04M
LEE KENNETH B JR
31 Jan 2023
Director
Exercised, kept
15,000
$1.71
$25.65K
Barnes Alane P
15 Dec 2022
Chief Legal Officer
Sell
4,175
$10.88
$45.42K
Jones Michael L
15 Dec 2022
Exec. Director, Finance - PAO
Sell
445
$10.90
$4.85K
Gayer Charles K
15 Dec 2022
Chief Commercial Officer
Sell
6,100
$10.90
$66.49K
Doyle Anthony
15 Dec 2022
Chief Financial Officer
Sell
5,700
$10.90
$62.13K
Thackray Helen M.
15 Dec 2022
Chief R&D Officer
Sell
3,125
$10.89
$34.03K
Stonehouse Jon P
15 Dec 2022
President & CEO
Sell
14,100
$10.90
$153.69K
Stonehouse Jon P
2 Dec 2022
President & CEO
Sold after exercise
82,656
$12.80
$1.06M
Stonehouse Jon P
1 Dec 2022
President & CEO
Sold after exercise
214,917
$13.00
$2.79M
Jones Michael L
1 Dec 2022
Exec. Director, Finance - PAO
Sold after exercise
8,600
$13.01
$111.89K
Babu Yarlagadda S
14 Nov 2022
Chief Discovery Officer
Sold after exercise
31,515
$13.88
$437.43K
ABERCROMBIE GEORGE B
18 Apr 2022
Director
Sold after exercise
5,000
$11.04
$55.20K
Thackray Helen M.
1 Apr 2022
Chief R&D Officer
Sell
7,600
$16.20
$123.12K
Sheridan William P
10 Mar 2022
Chief Medical Officer
Sold after exercise
1,400
$17.64
$24.70K
Sheridan William P
10 Mar 2022
Chief Medical Officer
Sold after exercise
159,739
$16.87
$2.69M
Babu Yarlagadda S
7 Mar 2022
Chief Discovery Officer
Sell
20,000
$17.16
$343.20K
Jones Michael L
1 Mar 2022
Exec. Director, Finance - PAO
Sold after exercise
2,300
$17.20
$39.56K
ABERCROMBIE GEORGE B
15 Feb 2022
Director
Sold after exercise
5,000
$18.50
$92.50K
Stonehouse Jon P
11 Jan 2022
President & CEO
Sold after exercise
184,000
$15.04
$2.77M
Babu Yarlagadda S
7 Dec 2021
Chief Discovery Officer
Sold after exercise
30,100
$12.20
$367.22K
MILANO VINCENT
24 Nov 2021
Director
Buy
7,500
$12.19
$91.43K
Doyle Anthony
23 Nov 2021
Chief Financial Officer
Buy
35,258
$12.48
$440.02K
ABERCROMBIE GEORGE B
15 Nov 2021
Director
Sold after exercise
5,000
$12.27
$61.35K
Hutson Nancy J
15 Oct 2021
Director
Sold after exercise
105,000
$15.40
$1.62M
ABERCROMBIE GEORGE B
15 Sep 2021
Director
Sold after exercise
5,000
$15.06
$75.30K
LEE KENNETH B JR
13 Sep 2021
Director
Sold after exercise
6,000
$15.35
$92.10K
ABERCROMBIE GEORGE B
10 Sep 2021
Director
Sold after exercise
74,000
$15.09
$1.12M
ABERCROMBIE GEORGE B
15 Jul 2021
Director
Sold after exercise
5,000
$15.69
$78.45K
Hutson Nancy J
10 Jun 2021
Director
Sold after exercise
23,333
$16.86
$393.39K
Sheridan William P
28 May 2021
Chief Medical Officer
Sold after exercise
91,814
$15.02
$1.38M
Sheridan William P
27 May 2021
Chief Medical Officer
Sold after exercise
71,759
$15.00
$1.08M
ABERCROMBIE GEORGE B
24 May 2021
Director
Sold after exercise
6,667
$13.90
$92.67K
Barnes Alane P
12 May 2021
Chief Legal Officer
Exercised, kept
35,852
$4.73
$169.58K
Barnes Alane P
11 May 2021
Chief Legal Officer
Sold after exercise
102,780
$12.04
$1.24M
ABERCROMBIE GEORGE B
10 May 2021
Director
Sell
7,000
$12.70
$88.90K
Jones Michael L
18 Mar 2021
Exec. Director, Finance - PAO
Exercised, kept
4,500
$3.51
$15.80K
Sheridan William P
22 Feb 2021
Senior VP - CMO
Sold after exercise
41,250
$11.57
$477.26K
Babu Yarlagadda S
19 Feb 2021
Senior VP - Drug Discovery
Exercised, kept
50,000
$4.15
$207.50K
Stonehouse Jon P
15 Dec 2020
President & CEO
Sold after exercise
134,278
$8.32
$1.12M
Barnes Alane P
11 Dec 2020
Senior VP, Chief Legal Officer
Sold after exercise
13,741
$7.96
$109.38K
Barnes Alane P
4 Dec 2020
Senior VP, Chief Legal Officer
Sold after exercise
13,741
$6.23
$85.61K
Doyle Anthony
11 Aug 2020
Chief Financial Officer
Buy
54,000
$4.08
$220.32K
ASELAGE STEVE
18 Nov 2019
Director
Buy
15,000
$1.45
$21.75K
Babu Yarlagadda S
18 Nov 2019
Senior VP - Drug Discovery
Buy
25,000
$1.45
$36.25K
Barnes Alane P
18 Nov 2019
Senior VP, Chief Legal Officer
Buy
20,000
$1.45
$29.00K
HEGGIE THERESA
18 Nov 2019
Director
Buy
5,000
$1.45
$7.25K
Hutson Nancy J
18 Nov 2019
Director
Buy
10,000
$1.45
$14.50K
INGRAM ROBERT ALEXANDER
18 Nov 2019
Director
Buy
20,000
$1.45
$29.00K
LEE KENNETH B JR
18 Nov 2019
Director
Buy
5,000
$1.45
$7.25K
Sniecinski Megan
18 Nov 2019
Chief Business Officer
Buy
45,000
$1.45
$65.25K
Stonehouse Jon P
18 Nov 2019
President & CEO
Buy
50,000
$1.45
$72.50K
ASELAGE STEVE
22 May 2019
Director
Buy
3,000
$3.57
$10.71K
STAAB THOMAS R II
17 May 2019
Senior Vice President and CFO
Sell
2,500
$7.45
$18.63K
STAAB THOMAS R II
16 May 2019
Senior Vice President and CFO
Sold after exercise
7,250
$7.72
$55.97K
STAAB THOMAS R II
15 May 2019
Senior Vice President and CFO
Sold after exercise
7,250
$7.92
$57.42K
STAAB THOMAS R II
14 May 2019
Senior Vice President and CFO
Sold after exercise
4,500
$7.62
$34.29K
STAAB THOMAS R II
13 May 2019
Senior Vice President and CFO
Sold after exercise
9,750
$7.76
$75.66K
STAAB THOMAS R II
9 May 2019
Senior Vice President and CFO
Sold after exercise
9,750
$7.63
$74.39K
STAAB THOMAS R II
6 May 2019
Senior Vice President and CFO
Sold after exercise
9,000
$7.75
$69.75K
STAAB THOMAS R II
2 May 2019
Senior Vice President and CFO
Sold after exercise
7,750
$7.30
$56.58K
STAAB THOMAS R II
4 Apr 2019
Senior Vice President and CFO
Sold after exercise
7,500
$8.81
$66.08K
ASELAGE STEVE
12 Mar 2019
Director
Buy
2,000
$8.30
$16.60K
Babu Yarlagadda S
31 Jan 2019
Senior VP - Drug Discovery
Exercised, kept
12,188
$1.20
$14.63K
Babu Yarlagadda S
31 Jan 2019
Senior VP - Drug Discovery
Exercised, kept
19,686
$1.20
$23.62K
Powell Lynne
28 Jan 2019
Senior VP - CCO
Sold after exercise
2,000
$9.91
$19.82K
Powell Lynne
28 Jan 2019
Senior VP - CCO
Sold after exercise
4,000
$9.88
$39.52K
STAAB THOMAS R II
28 Jan 2019
Senior Vice President and CFO
Sold after exercise
5,000
$9.85
$49.25K
Powell Lynne
25 Jan 2019
Senior VP - CCO
Sold after exercise
6,000
$9.60
$57.60K
Powell Lynne
18 Jan 2019
Senior VP - CCO
Sold after exercise
2,000
$9.40
$18.80K
Powell Lynne
16 Jan 2019
Senior VP - CCO
Sold after exercise
3,046
$9.27
$28.24K
Powell Lynne
14 Jan 2019
Senior VP - CCO
Sold after exercise
954
$9.20
$8.78K
Sheridan William P
18 Dec 2018
Senior VP - CMO
Sell
20,488
$7.58
$155.30K
Powell Lynne
10 Dec 2018
Senior VP - CCO
Sold after exercise
2,000
$9.11
$18.22K
Powell Lynne
10 Dec 2018
Senior VP - CCO
Sold after exercise
2,000
$9.01
$18.02K
STAAB THOMAS R II
4 Dec 2018
Senior Vice President and CFO
Sell
3,922
$9.45
$37.06K
Stonehouse Jon P
3 Dec 2018
President & CEO
Sold after exercise
80,000
$9.12
$729.60K
Barnes Alane P
30 Nov 2018
Senior VP, Chief Legal Officer
Sold after exercise
44,290
$9.07
$401.71K
Erck Stanley C
28 Nov 2018
Director
Exercised, kept
8,333
$1.49
$12.42K
STAAB THOMAS R II
23 Nov 2018
Senior Vice President and CFO
Sold after exercise
3,500
$9.66
$33.81K
STAAB THOMAS R II
21 Nov 2018
Senior Vice President and CFO
Sold after exercise
7,000
$9.08
$63.56K
STAAB THOMAS R II
21 Nov 2018
Senior Vice President and CFO
Sold after exercise
5,000
$9.41
$47.05K
Powell Lynne
21 Nov 2018
Senior VP - CCO
Sold after exercise
2,455
$9.01
$22.12K
Powell Lynne
21 Nov 2018
Senior VP - CCO
Sold after exercise
12,000
$9.06
$108.72K
STAAB THOMAS R II
20 Nov 2018
Senior Vice President and CFO
Sold after exercise
6,500
$8.75
$56.88K
STAAB THOMAS R II
20 Nov 2018
Senior Vice President and CFO
Sold after exercise
4,623
$8.57
$39.62K
Powell Lynne
20 Nov 2018
Senior VP - CCO
Sold after exercise
6,150
$8.61
$52.95K
Powell Lynne
20 Nov 2018
Senior VP - CCO
Sold after exercise
9,127
$8.52
$77.76K
STAAB THOMAS R II
19 Nov 2018
Senior Vice President and CFO
Sold after exercise
75
$8.30
$622.50
Powell Lynne
19 Nov 2018
Senior VP - CCO
Sold after exercise
193
$8.30
$1.60K
Powell Lynne
8 Nov 2018
Senior VP - CCO
Sold after exercise
5,280
$8.15
$43.03K
STAAB THOMAS R II
8 Nov 2018
Senior Vice President and CFO
Sold after exercise
2,302
$8.30
$19.11K
STAAB THOMAS R II
8 Nov 2018
Senior Vice President and CFO
Sold after exercise
11,113
$8.09
$89.90K
Powell Lynne
7 Nov 2018
Senior VP - CCO
Sold after exercise
300
$8.00
$2.40K
STAAB THOMAS R II
7 Nov 2018
Senior Vice President and CFO
Sold after exercise
672
$8.00
$5.38K
STAAB THOMAS R II
5 Nov 2018
Senior Vice President and CFO
Sold after exercise
215
$8.00
$1.72K
Powell Lynne
5 Nov 2018
Senior VP - CCO
Sold after exercise
100
$8.00
$800.00
STAAB THOMAS R II
2 Nov 2018
Senior Vice President and CFO
Sold after exercise
3,500
$7.96
$27.86K
STAAB THOMAS R II
2 Nov 2018
Senior Vice President and CFO
Sold after exercise
7,356
$7.78
$57.23K
Powell Lynne
2 Nov 2018
Senior VP - CCO
Sold after exercise
1,000
$8.00
$8.00K
Powell Lynne
1 Nov 2018
Senior VP - CCO
Sell
1,544
$7.51
$11.60K
Powell Lynne
19 Oct 2018
Senior VP - CCO
Sell
100
$7.50
$750.00
STAAB THOMAS R II
19 Oct 2018
Senior Vice President and CFO
Sold after exercise
3,150
$7.45
$23.47K
STAAB THOMAS R II
3 Oct 2018
Senior Vice President and CFO
Sold after exercise
100
$7.45
$745.00
STAAB THOMAS R II
3 Oct 2018
Senior Vice President and CFO
Sold after exercise
972
$7.26
$7.06K
STAAB THOMAS R II
2 Oct 2018
Senior Vice President and CFO
Sold after exercise
5,528
$7.27
$40.19K
STAAB THOMAS R II
2 Oct 2018
Senior Vice President and CFO
Sold after exercise
3,250
$7.19
$23.37K
Sheridan William P
9 Aug 2018
Senior VP - CMO
Sold after exercise
62,500
$7.03
$439.38K
Sheridan William P
1 Jun 2018
Senior VP - CMO
Sold after exercise
42,112
$6.30
$265.31K
Stonehouse Jon P
17 May 2018
President & CEO
Exercised, kept
70,427
$1.42
$100.01K
Barnes Alane P
15 May 2018
VP, General Counsel & Corp Sec
Exercised, kept
12,500
$1.42
$17.75K
Babu Yarlagadda S
6 Mar 2018
Senior VP - Drug Discovery
Exercised, kept
9,378
$3.26
$30.57K
Babu Yarlagadda S
6 Mar 2018
Senior VP - Drug Discovery
Exercised, kept
20,622
$3.26
$67.23K
Barnes Alane P
28 Feb 2018
VP, General Counsel & Corp Sec
Exercised, kept
6,709
$3.26
$21.87K
Stonehouse Jon P
28 Feb 2018
President & CEO
Exercised, kept
56,949
$3.26
$185.65K
Sheridan William P
13 Nov 2017
Senior VP - CMO
Sell
64,310
$4.72
$303.54K
Cohen Fred E
18 Sep 2017
Director
Sold after exercise
54,250
$5.42
$294.04K
STAAB THOMAS R II
22 May 2017
Senior Vice President and CFO
Exercised, kept
7,750
$4.73
$36.66K
STAAB THOMAS R II
20 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$9.20
$29.90K
STAAB THOMAS R II
16 Mar 2017
Senior Vice President and CFO
Exercised, kept
12,500
$1.42
$17.75K
STAAB THOMAS R II
16 Mar 2017
Senior Vice President and CFO
Exercised, kept
23,955
$3.78
$90.55K
STAAB THOMAS R II
10 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$9.06
$29.45K
STAAB THOMAS R II
8 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$8.65
$28.11K
STAAB THOMAS R II
8 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$8.20
$26.65K
STAAB THOMAS R II
6 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$7.90
$25.68K
STAAB THOMAS R II
19 Dec 2016
Senior Vice President and CFO
Sold after exercise
3,250
$7.45
$24.21K

What was left out

Form 4 filings counted 457
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 86
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 8,263,448
Sales filed before the plan box existed 15
History held since 6 Sep 2016